↓ Skip to main content

Dove Medical Press

Dabrafenib: a new opportunity for the treatment of BRAF V600-positive melanoma

Overview of attention for article published in OncoTargets and therapy, May 2016
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (75th percentile)
  • High Attention Score compared to outputs of the same age and source (89th percentile)

Mentioned by

news
1 news outlet

Citations

dimensions_citation
26 Dimensions

Readers on

mendeley
59 Mendeley
Title
Dabrafenib: a new opportunity for the treatment of BRAF V600-positive melanoma
Published in
OncoTargets and therapy, May 2016
DOI 10.2147/ott.s75104
Pubmed ID
Authors

Maria Banzi, Simona De Blasio, Aimilios Lallas, Caterina Longo, Elvira Moscarella, Roberto Alfano, Giuseppe Argenziano

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 59 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 59 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 11 19%
Student > Bachelor 11 19%
Researcher 8 14%
Student > Doctoral Student 4 7%
Other 3 5%
Other 8 14%
Unknown 14 24%
Readers by discipline Count As %
Medicine and Dentistry 15 25%
Biochemistry, Genetics and Molecular Biology 12 20%
Agricultural and Biological Sciences 6 10%
Pharmacology, Toxicology and Pharmaceutical Science 5 8%
Chemistry 2 3%
Other 4 7%
Unknown 15 25%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 May 2016.
All research outputs
#4,947,179
of 25,806,080 outputs
Outputs from OncoTargets and therapy
#222
of 3,016 outputs
Outputs of similar age
#70,567
of 312,788 outputs
Outputs of similar age from OncoTargets and therapy
#13
of 123 outputs
Altmetric has tracked 25,806,080 research outputs across all sources so far. Compared to these this one has done well and is in the 79th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,016 research outputs from this source. They receive a mean Attention Score of 2.9. This one has done particularly well, scoring higher than 91% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 312,788 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 75% of its contemporaries.
We're also able to compare this research output to 123 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 89% of its contemporaries.